It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2005.
2005 | Mumbai, Maharashtra, India | Under LiquidationActis Biologics Private Limited, a under liquidation private limited company, was established on 27 December 2005 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230MH2005PTC158347. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.15 Cr and a paid-up capital of ₹5.40 Cr.
Its leadership includes Sanjeev Kirpachandra Saxena (Director), Savita Saxena (Director). Past directors included Mukund Dharamdas Dalal, Dhiren Bhogilal Kothary, Sudhir Bhagawant Karnik. It holds ₹11.77 Cr open charges and no settled loans. Its latest AGM occurred on 13 December 2010, with the balance sheet filed on 31 March 2010. It is based at 201, Vedanta, Makwana Road, Off Andheri-Kurla Road Marol, Andheri (East), Mumbai, Maharashtra, 400049.
U24230MH2005PTC158347
158347
27 December 2005
₹6.15 Cr
₹5.40 Cr
Roc Mumbai
Unlisted
Under Liquidation
Explore comprehensive insights into Actis Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjeev Kirpachandra Saxena | Director | 27 Dec 2005 | Current |
| Savita Saxena | Director | 27 Dec 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Jun 2010 | Past |
| Pramod Abcsdd | Director | 12 Jun 2010 | Past |
| Pramod Abcsdd | Alternate Director | 25 Jun 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Actis Biologics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Actis Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹117,719,026.19
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jul 2009 | Department Of Biotechnology | ₹2.73 Cr | Open |
| 10 Jul 2008 | Phoenix Arc Private Limited | ₹9.05 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Actis Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Actis Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Actis Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Phoenix Arc Private Limited of Rs. 9.05 Cr registered on 10 Jul 2008 with Charge ID 10131783 was modified on 26 Mar 2013. was completed.
The activity Actis Biologics Private Limited last Annual general meeting of members was held on 13 Dec 2010 as per latest MCA records. was completed.
Actis Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Mumbai. was recorded as a recent event.
A charge with Department Of Biotechnology amounted to Rs. 2.73 Cr with Charge ID 10168624 was registered on 01 Jul 2009. was recorded as a recent event.
The activity A charge with Phoenix Arc Private Limited amounted to Rs. 9.05 Cr with Charge ID 10131783 was registered on 10 Jul 2008. was completed.
Sanjeev Kirpachandra Saxena was appointed as a Director was appointed as a Director on 27 Dec 2005 & has been associated with this company since 19 years 11 months . was recorded as a recent event.
The CIN of Actis Biologics Private Limited is U24230MH2005PTC158347.
Actis Biologics Private Limited is headquartered at 201, Vedanta, Makwana Road, Off Andheri-Kurla Road Marol, Andheri (East), Mumbai, Maharashtra, 400049.
Actis Biologics Private Limited was incorporated on 27 December 2005.
The current directors of Actis Biologics Private Limited are
The primary industry of Actis Biologics Private Limited is Chemicals.
Actis Biologics Private Limited is unlisted.
The authorized capital of Actis Biologics Private Limited is ₹6.15 Cr, and the paid-up capital is ₹5.40 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX